Literature DB >> 2940340

Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia.

M Duijndam-van den Berge, J G Goekoop.   

Abstract

Lymphocyte capping with concanavalin A was studied in adult patients with Down's syndrome and aged patients with primary degenerative dementia. In both disorders a decreased capping was found as compared with age-matched and clinically relevant control groups. Colchicine had a strong enhancing effect on capping in Down's syndrome. In primary degenerative dementia the enhancing effect of colchicine was restricted to a subgroup of patients with onset of the dementing illness before the age of 80 years.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940340      PMCID: PMC1028817          DOI: 10.1136/jnnp.49.5.595

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  3 in total

1.  Alzheimer's disease, trisomy 21, and myeloproliferative disorders: associations suggesting a genetic diathesis.

Authors:  L L Heston
Journal:  Science       Date:  1977-04-15       Impact factor: 47.728

2.  Changes in concanavalin A capping of human lymphocytes with age.

Authors:  A B Noronha; J P Antel; R P Roos; B G Arnason
Journal:  Mech Ageing Dev       Date:  1980-04       Impact factor: 5.432

3.  Pathological verification of ischemic score in differentiation of dementias.

Authors:  W G Rosen; R D Terry; P A Fuld; R Katzman; A Peck
Journal:  Ann Neurol       Date:  1980-05       Impact factor: 10.422

  3 in total
  3 in total

1.  Lymphocyte concanavalin A capping in hereditary cerebral haemorrhage with amyloidosis--Dutch type.

Authors:  J Haan; R T Demmers; O J Buruma; R A Roos
Journal:  J Neurol       Date:  1990-04       Impact factor: 4.849

2.  Lymphocyte capping in Down's syndrome and Alzheimer's disease.

Authors:  D Brohée
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

3.  Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease.

Authors:  Karol Dowjat; Tatyana Adayev; Urszula Wojda; Katarzyna Brzozowska; Anna Barczak; Tomasz Gabryelewicz; Yu-Wen Hwang
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.